SS Innovations International (SSII) Return on Capital Employed Growth (1y) (2018 - 2026)
SS Innovations International (SSII) Return on Capital Employed Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.85 Bn | 176.55 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 108.55 Bn | 99.33 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn | -110.00 |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 658.00 |
| 7 | GE HealthCare Technologies | 28.15 Bn | 25.87 Bn | 1.98 Bn | -3,185.00 |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.75 Bn | 21.63 Bn | 2.07 Bn | 125.00 |
| 10 | SS Innovations International | 784.03 Mn | 760.42 Mn | 5.33 Mn | 2,888.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,888.00 |
| Dec 31, 2025 | 7,956.00 |
| Sep 30, 2025 | 13,592.00 |
| Jun 30, 2025 | 11,353.00 |
| Mar 31, 2025 | 10,312.00 |
| Dec 31, 2024 | -304.00 |
| Sep 30, 2024 | -7,922.00 |
| Jun 30, 2024 | 69,044.00 |
| Mar 31, 2024 | 13,765.00 |
| Dec 31, 2023 | -15,598.00 |
| Sep 30, 2023 | -52,622.00 |
| Jun 30, 2023 | 72,279.00 |
| Mar 31, 2023 | 77,558.00 |
| Dec 31, 2022 | 163,639.00 |
| Sep 30, 2022 | 29,781.00 |
| Jun 30, 2022 | -170,485.00 |
| Mar 31, 2022 | -119,002.00 |
| Dec 31, 2021 | -168,744.00 |
| Sep 30, 2021 | 321.00 |
| Jun 30, 2021 | -4,454.00 |